-+ 0.00%
-+ 0.00%
-+ 0.00%

Organogenesis Holdings Narrows FY2026 Sales Guidance from $179.000M-$215.000M to $179.400M-$200.000M vs $196.050M Est

Benzinga·11/05/2026 21:09:11
Listen to the news
Organogenesis Holdings (NASDAQ:ORGO) narrows FY2026 sales outlook from $179.000 million-$215.000 million to $179.400 million-$200.000 million vs $196.050 million estimate.